Literature DB >> 35237749

A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases.

Julia Y Wang1, Michael W Roehrl1, Victor B Roehrl1, Michael H Roehrl2,3,4.   

Abstract

Chronic and debilitating autoimmune sequelae pose a grave concern for the post-COVID-19 pandemic era. Based on our discovery that the glycosaminoglycan dermatan sulfate (DS) displays peculiar affinity to apoptotic cells and autoantigens (autoAgs) and that DS-autoAg complexes cooperatively stimulate autoreactive B1 cell responses, we compiled a database of 751 candidate autoAgs from six human cell types. At least 657 of these have been found to be affected by SARS-CoV-2 infection based on currently available multi-omic COVID data, and at least 400 are confirmed targets of autoantibodies in a wide array of autoimmune diseases and cancer. The autoantigen-ome is significantly associated with various processes in viral infections, such as translation, protein processing, and vesicle transport. Interestingly, the coding genes of autoAgs predominantly contain multiple exons with many possible alternative splicing variants, short transcripts, and short UTR lengths. These observations and the finding that numerous autoAgs involved in RNA-splicing showed altered expression in viral infections suggest that viruses exploit alternative splicing to reprogram host cell machinery to ensure viral replication and survival. While each cell type gives rise to a unique pool of autoAgs, 39 common autoAgs associated with cell stress and apoptosis were identified from all six cell types, with several being known markers of systemic autoimmune diseases. In particular, the common autoAg UBA1 that catalyzes the first step in ubiquitination is encoded by an X-chromosome escape gene. Given its essential function in apoptotic cell clearance and that X-inactivation escape tends to increase with aging, UBA1 dysfunction can therefore predispose aging women to autoimmune disorders. In summary, we propose a model of how viral infections lead to extensive molecular alterations and host cell death, autoimmune responses facilitated by autoAg-DS complexes, and ultimately autoimmune diseases. Overall, this master autoantigen-ome provides a molecular guide for investigating the myriad of autoimmune sequalae to COVID-19 and clues to the rare adverse effects of the currently available mRNA and viral vector-based COVID vaccines.
© 2022 Published by Elsevier B.V.

Entities:  

Keywords:  Alternative Splicing; Autoantibodies; Autoantigens; Autoimmune Diseases; Autoimmunity; COVID-19; DS, dermatan sulfate; SARS-CoV-2; autoAb, autoantibody; autoAg, autoantigen

Year:  2022        PMID: 35237749      PMCID: PMC8872718          DOI: 10.1016/j.jtauto.2022.100147

Source DB:  PubMed          Journal:  J Transl Autoimmun        ISSN: 2589-9090


  41 in total

1.  Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations.

Authors:  Stefan Schoeftner; Raquel Blanco; Isabel Lopez de Silanes; Purificación Muñoz; Gonzalo Gómez-López; Juana M Flores; Maria A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

2.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

3.  ShinyGO: a graphical gene-set enrichment tool for animals and plants.

Authors:  Steven Xijin Ge; Dongmin Jung; Runan Yao
Journal:  Bioinformatics       Date:  2020-04-15       Impact factor: 6.937

4.  Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.

Authors:  Mingfeng Liao; Yang Liu; Jing Yuan; Yanling Wen; Gang Xu; Juanjuan Zhao; Lin Cheng; Jinxiu Li; Xin Wang; Fuxiang Wang; Lei Liu; Ido Amit; Shuye Zhang; Zheng Zhang
Journal:  Nat Med       Date:  2020-05-12       Impact factor: 53.440

5.  Landscape of X chromosome inactivation across human tissues.

Authors:  Taru Tukiainen; Alexandra-Chloé Villani; Angela Yen; Manuel A Rivas; Jamie L Marshall; Rahul Satija; Matt Aguirre; Laura Gauthier; Mark Fleharty; Andrew Kirby; Beryl B Cummings; Stephane E Castel; Konrad J Karczewski; François Aguet; Andrea Byrnes; Tuuli Lappalainen; Aviv Regev; Kristin G Ardlie; Nir Hacohen; Daniel G MacArthur
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

6.  Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

Authors:  Alexey Stukalov; Virginie Girault; Vincent Grass; Ozge Karayel; Valter Bergant; Christian Urban; Darya A Haas; Yiqi Huang; Lila Oubraham; Anqi Wang; M Sabri Hamad; Antonio Piras; Fynn M Hansen; Maria C Tanzer; Igor Paron; Luca Zinzula; Thomas Engleitner; Maria Reinecke; Teresa M Lavacca; Rosina Ehmann; Roman Wölfel; Jörg Jores; Bernhard Kuster; Ulrike Protzer; Roland Rad; John Ziebuhr; Volker Thiel; Pietro Scaturro; Matthias Mann; Andreas Pichlmair
Journal:  Nature       Date:  2021-04-12       Impact factor: 49.962

7.  SARS-CoV-2 productively infects human gut enterocytes.

Authors:  Mart M Lamers; Joep Beumer; Jelte van der Vaart; Bart L Haagmans; Hans Clevers; Kèvin Knoops; Jens Puschhof; Tim I Breugem; Raimond B G Ravelli; J Paul van Schayck; Anna Z Mykytyn; Hans Q Duimel; Elly van Donselaar; Samra Riesebosch; Helma J H Kuijpers; Debby Schipper; Willine J van de Wetering; Miranda de Graaf; Marion Koopmans; Edwin Cuppen; Peter J Peters
Journal:  Science       Date:  2020-05-01       Impact factor: 47.728

8.  Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies.

Authors:  Jonathan P Davies; Katherine M Almasy; Eli F McDonald; Lars Plate
Journal:  ACS Infect Dis       Date:  2020-12-02       Impact factor: 5.084

Review 9.  Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.

Authors:  Jan Damoiseaux; Arad Dotan; Marvin J Fritzler; Dimitrios P Bogdanos; Pier Luigi Meroni; Dirk Roggenbuck; Michel Goldman; Nils Landegren; Paul Bastard; Yehuda Shoenfeld; Karsten Conrad
Journal:  Autoimmun Rev       Date:  2021-12-09       Impact factor: 9.754

10.  Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.

Authors:  Yong Xiong; Yuan Liu; Liu Cao; Dehe Wang; Ming Guo; Ao Jiang; Dong Guo; Wenjia Hu; Jiayi Yang; Zhidong Tang; Honglong Wu; Yongquan Lin; Meiyuan Zhang; Qi Zhang; Mang Shi; Yingle Liu; Yu Zhou; Ke Lan; Yu Chen
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

View more
  1 in total

Review 1.  NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.

Authors:  Yuanfeng Zhu; Xiaoli Chen; Xin Liu
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.